- Phase 1 since 5 Aug 2026: Huons Global’s first study of it at that phase, by the day it was submitted to ClinicalTrials.gov.
- Next primary completion: Apr 2027, the registry's estimate, of NCT07784608 (phase 1) — when its main measure’s data collection ends, not when results are announced.study pageClinicalTrials.gov ↗
- One program: SCH412387Judged by our rule (version d2907d7): the same study entry names both · 2026-11-14
- One program: MK9396Judged by our rule (version d2907d7): the same study entry names both · 2026-11-14
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 2 studies AstraZeneca leads of it in the last 24 months also tests elecoglipron, rosuvastatin.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Jiangsu HengRui Medicine Co., Ltd. leads of it also tests HRS-1301.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies HealthBio, Inc. leads of it also tests Maraviroc.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 2 studies Merck & Co., Inc leads of it in the last 24 months also tests ulonivirine, MK-0616.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 2 studies Novo Nordisk A/S leads of it also tests cagrilintide, Liraglutide, Griseofulvin.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Huadong Medicine Co., Ltd. leads of it in the last 24 months also tests HDM1005.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Altimmune, Inc. leads of it also tests pemvidutide.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies NewAmsterdam Pharma leads of it also tests TA-8995.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 2 studies Johnson & Johnson leads of it also tests milvexian, Simeprevir.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Otsuka Holdings Co., Ltd. leads of it also tests Probucol, Cilostazol.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 6 studies Boryung Pharmaceutical Co., Ltd leads of it also tests fimasartan.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Ascletis Pharma Inc. leads of it also tests ASC42.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 8 studies Eli Lilly and Company leads of it also tests evacetrapib, LY3478045, naperiglipron.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Eccogene leads of it also tests elecoglipron.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Pharmtechnology LLC leads of it also tests Liprimar® film-coated tablet 40 mg.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Innovent Biologics, Inc. leads of it also tests mazdutide.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Chipscreen Biosciences, Ltd. leads of it also tests chiglitazar.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 4 studies Sanofi leads of it also tests alirocumab, Lovastatin, Fluvastatin.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 2 studies Amgen leads of it also tests evolocumab.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 2 studies HK inno.N Corporation leads of it also tests tegoprazan, cj-30056.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 2 studies NeuroBo Pharmaceuticals Inc. leads of it also tests gemcabene.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Dong-A ST Co., Ltd. leads of it also tests Dong-A Atorvastatin 80mg Tab → Lipitor 80mg Tab.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 2 studies Chiesi Farmaceutici S.p.A. leads of it also tests BMS201038.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Hoffmann-La Roche leads of it also tests dalcetrapib.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Handok Inc. leads of it also tests teneligliptin.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Esperion Therapeutics, Inc. leads of it also tests bempedoic acid.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Akebia Therapeutics leads of it also tests vadadustat.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Zhejiang Hisun Pharmaceutical Co. Ltd. leads of it also tests HS-25.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 3 studies Boehringer Ingelheim leads of it also tests Dabigatran, faldaprevir, tipranavir.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies AbbVie leads of it also tests Digoxin.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Madrigal Pharmaceuticals, Inc. leads of it also tests resmetirom.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 2 studies Takeda leads of it also tests relugolix, Pioglitazone.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Regeneron Pharmaceuticals leads of it also tests alirocumab.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Gilead Sciences leads of it also tests seladelpar.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Resverlogix Corp leads of it also tests apabetalone.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Bristol-Myers Squibb leads of it also tests BMS-919373.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 3 studies Abbott leads of it also tests Niacin, choline fenofibrate, Fenofibrate.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Mutual Pharmaceutical Company, Inc. leads of it also tests Colchicine.
- Given alongside, not the company's programJudged by our rule (version d2907d7): an approved drug many companies test, given beside the company's own in each of its studies · 2026-11-14Approved and tested by 61 companies; each of the 1 studies Kowa Company, Ltd. leads of it also tests pitavastatin.
|